This chapter provides a comprehensive overview of pharmacologic and non-pharmacologic treatment strategies tailored to the diverse etiologies of major neurocognitive disorders (NCDs). While Alzheimer’s disease remains the most common cause, the chapter also explores a few therapeutic approaches for vascular dementia, frontotemporal dementia, Lewy body dementia, Parkinson’s disease dementia, HIV-associated neurocognitive disorders, and others. Treatment decisions are discussed in the context of pathophysiologic mechanisms, clinical manifestations, and evidence-based recommendations unique to each disorder.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Cognitive Enhancers for Neurocognitive Disorders

  • Heta D. Rajyaguru,
  • Wm Maurice Redden,
  • George T. Grossberg

摘要

This chapter provides a comprehensive overview of pharmacologic and non-pharmacologic treatment strategies tailored to the diverse etiologies of major neurocognitive disorders (NCDs). While Alzheimer’s disease remains the most common cause, the chapter also explores a few therapeutic approaches for vascular dementia, frontotemporal dementia, Lewy body dementia, Parkinson’s disease dementia, HIV-associated neurocognitive disorders, and others. Treatment decisions are discussed in the context of pathophysiologic mechanisms, clinical manifestations, and evidence-based recommendations unique to each disorder.